117 related articles for article (PubMed ID: 31529849)
1. Clostridium difficile infection: Description of NAP1/027 and non NAP1/027 strains in a high complexity center in Cali, Colombia, 2012-2015.
Oñate-Gutiérrez JM; Segura J; Correa A; Cantor E; Villegas MV
Biomedica; 2019 May; 39(s1):63-70. PubMed ID: 31529849
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics of Clostridium difficile infection in a high complexity hospital and report of the circulation of the NAP1/027 hypervirulent strain in Colombia].
Gualtero SM; Abril LA; Camelo N; Sanchez SD; Davila FA; Arias G; Silva E; Bustos IG; Josa DF; Torres IC; Zambrano LC; Pareja MJ
Biomedica; 2017 Dec; 37(4):466-472. PubMed ID: 29373767
[TBL] [Abstract][Full Text] [Related]
3. The evolving epidemiology of
Katz KC; Golding GR; Choi KB; Pelude L; Amaratunga KR; Taljaard M; Alexandre S; Collet JC; Davis I; Du T; Evans GA; Frenette C; Gravel D; Hota S; Kibsey P; Langley JM; Lee BE; Lemieux C; Longtin Y; Mertz D; Mieusement LMD; Minion J; Moore DL; Mulvey MR; Richardson S; Science M; Simor AE; Stagg P; Suh KN; Taylor G; Wong A; Thampi N;
CMAJ; 2018 Jun; 190(25):E758-E765. PubMed ID: 29941432
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
[TBL] [Abstract][Full Text] [Related]
5. Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infection.
Bauer KA; Johnston JEW; Wenzler E; Goff DA; Cook CH; Balada-Llasat JM; Pancholi P; Mangino JE
Anaerobe; 2017 Dec; 48():1-6. PubMed ID: 28645479
[TBL] [Abstract][Full Text] [Related]
6. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.
Miller M; Gravel D; Mulvey M; Taylor G; Boyd D; Simor A; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S
Clin Infect Dis; 2010 Jan; 50(2):194-201. PubMed ID: 20025526
[TBL] [Abstract][Full Text] [Related]
7. Spread of epidemic Clostridium difficile NAP1/027 in Latin America: case reports in Panama.
López-Ureña D; Quesada-Gómez C; Miranda E; Fonseca M; Rodríguez-Cavallini E
J Med Microbiol; 2014 Feb; 63(Pt 2):322-324. PubMed ID: 24287669
[TBL] [Abstract][Full Text] [Related]
8. Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
López-Ureña D; Quesada-Gómez C; Montoya-Ramírez M; del Mar Gamboa-Coronado M; Somogyi T; Rodríguez C; Rodríguez-Cavallini E
Emerg Microbes Infect; 2016 May; 5(5):e42. PubMed ID: 27165560
[TBL] [Abstract][Full Text] [Related]
9. Recent changes in Clostridium difficile infection.
Silva Júnior M
Einstein (Sao Paulo); 2012; 10(1):105-9. PubMed ID: 23045838
[TBL] [Abstract][Full Text] [Related]
10. Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infection.
Thabit AK; Housman ST; Burnham CD; Nicolau DP
J Hosp Infect; 2016 Feb; 92(2):167-72. PubMed ID: 26792686
[TBL] [Abstract][Full Text] [Related]
11. Host and pathogen factors for Clostridium difficile infection and colonization.
Loo VG; Bourgault AM; Poirier L; Lamothe F; Michaud S; Turgeon N; Toye B; Beaudoin A; Frost EH; Gilca R; Brassard P; Dendukuri N; Béliveau C; Oughton M; Brukner I; Dascal A
N Engl J Med; 2011 Nov; 365(18):1693-703. PubMed ID: 22047560
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular characteristics of an outbreak caused by the pandemic (BI/NAP1/027) Clostridium difficile clone in a single center in Israel.
Wiener-Well Y; Ben-Chetrit E; Abed-Eldaim M; Assous MV; Miller-Roll T; Adler A
Infect Control Hosp Epidemiol; 2014 Oct; 35(10):1306-8. PubMed ID: 25203189
[No Abstract] [Full Text] [Related]
13. First report of Clostridium difficile NAP1/027 in a Mexican hospital.
Camacho-Ortiz A; López-Barrera D; Hernández-García R; Galván-De Los Santos AM; Flores-Treviño SM; Llaca-Díaz JM; Maldonado-Garza HJ; Bosques-Padilla FJ; Garza-González E
PLoS One; 2015; 10(4):e0122627. PubMed ID: 25915544
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile outbreak caused by NAP1/BI/027 strain and non-027 strains in a Mexican hospital.
Morfin-Otero R; Garza-Gonzalez E; Aguirre-Diaz SA; Escobedo-Sanchez R; Esparza-Ahumada S; Perez-Gomez HR; Petersen-Morfin S; Gonzalez-Diaz E; Martinez-Melendez A; Rodriguez-Noriega E;
Braz J Infect Dis; 2016; 20(1):8-13. PubMed ID: 26620948
[TBL] [Abstract][Full Text] [Related]
15. Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics.
van Beurden YH; Nezami S; Mulder CJJ; Vandenbroucke-Grauls CMJE
Clin Microbiol Infect; 2018 Jan; 24(1):85.e1-85.e4. PubMed ID: 28782647
[TBL] [Abstract][Full Text] [Related]
16. High rate of Clostridium difficile among young adults presenting with diarrhea at two hospitals in Kenya.
Oyaro MO; Plants-Paris K; Bishoff D; Malonza P; Gontier CS; DuPont HL; Darkoh C
Int J Infect Dis; 2018 Sep; 74():24-28. PubMed ID: 29960098
[TBL] [Abstract][Full Text] [Related]
17. Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.
Fawley WN; Davies KA; Morris T; Parnell P; Howe R; Wilcox MH;
Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27487436
[TBL] [Abstract][Full Text] [Related]
18. [Infections caused by Clostridium difficile].
Rodríguez-Pardo D; Mirelis B; Navarro F
Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):254-63. PubMed ID: 23411363
[TBL] [Abstract][Full Text] [Related]
19. [Case series of Clostridium difficile NAP1/027/BI with novels treatments].
Pérez-Topete SE; Miranda-Aquino T; Ayala-Gaytan JJ
Rev Med Inst Mex Seguro Soc; 2017; 55(5):654-659. PubMed ID: 29193949
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
Berger FK; Rasheed SS; Araj GF; Mahfouz R; Rimmani HH; Karaoui WR; Sharara AI; Dbaibo G; Becker SL; von Müller L; Bischoff M; Matar GM; Gärtner B
Int J Med Microbiol; 2018 Apr; 308(3):358-363. PubMed ID: 29478838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
